Regulus Therapeutics Inc. buy SVB Leerink LLC
Start price
18.03.24
/
50%
€2.10
Target price
18.03.25
€5.51
Performance (%)
-40.48%
End price
19.03.25
€1.25
Summary
This prediction ended on 19.03.25 with a price of €1.25. Massive losses of -40.48% were the result for the BUY prediction by SVB_Leerink_LLC. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regulus Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 3,02 % | 2,20 % | 14,66 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % | 31,41 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % | 49,42 % |
| iShares S&P 500 | 2,64 % | 1,01 % | 25,12 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Regulus Therapeutics Inc. diskutieren
Regulus Therapeutics Inc. (NASDAQ: RGLS) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $6.00 price target on the stock.
Ratings data for RGLS provided by MarketBeat
In the thread Trading Regulus Therapeutics Inc.
Die von SVB_Leerink_LLC gewählte maximale Laufzeit wurde überschritten